AI drug development's data problem.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 40208973.
- Also identified by DOI 10.1126/science.adx0339.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The future of drug discovery may be artificial intelligence (AI), but its present is not. AI is in its infancy in the field. To help AI mature, developers need nonproprietary, open, large, high-quality datasets to train and validate models, managed by independent organizations.
Medical subject headings
- Artificial Intelligence
- Drug Development
- Drug Discovery